Impact of switching to second-generation antipsychotics on the treatment of long-term inpatients with schizophrenia

被引：0
|
作者：
Yamawaki, Y. [1 ]
Yoshino, A. [2 ]
Sawa, M. [2 ]
Jin-nin, R. [3 ]
Tamai, K. [2 ]
Adachi, T. [2 ]
Yukutake, E. [2 ]
Toki, S. [3 ]
Oyamada, T. [2 ]
Takahashi, T. [2 ]
Akagi, H. [4 ]
机构：
[1] Hiroshima Int Univ, Hiroshima, Japan
[2] Mihara Hosp, Kyoto, Japan
[3] Hiroshima Univ, Dept Psychiat, Hiroshima 730, Japan
[4] Hiroshima Int Univ, Dept Pharm, Kure, Japan
来源：
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY | 2012年 / 15卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P-01-068
引用
收藏
页码：65 / 65
页数：1
相关论文
共 50 条
  • [41] Interim-analysis of a long-term treatment study with long-acting injectable risperidone and oral second generation antipsychotics in schizophrenia
    Ibach, B.
    Schreiner, A.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2008, 18 : S437 - S437
  • [42] A pilot study of adjunctive atomoxetine treatment to second-generation antipsychotics for cognitive impairment in schizophrenia
    Friedman, Joseph I.
    Carpenter, David
    Lu, Jing
    Fan, Jin
    Tang, Cheuk Y.
    White, Leonard
    Parrella, Michael
    Bowler, Stephanie
    Elbaz, Zeinab
    Flanagan, Lauren
    Harvey, Philip D.
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2008, 28 (01) : 59 - 63
  • [43] Treatment adherence and persistence with oral second-generation antipsychotics in patients with schizophrenia in Spain and Denmark
    Emborg, C.
    Jorgensen, K. T.
    Rosenlund, M.
    Simonsen, K. Starup
    McMahon, P.
    Nylander, A. G.
    Wang-Silvanto, J.
    Bobes, J.
    EUROPEAN PSYCHIATRY, 2019, 56 : S256 - S256
  • [44] Long-term metabolic side effects of second-generation antipsychotics in Chinese patients with schizophrenia: A within-subject approach with modelling of dosage effects
    Wong, Kenneth Chi-Yin
    Leung, Perry Bok-Man
    Lee, Benedict Ka-Wa
    Sham, Pak-Chung
    Lui, Simon Sai-Yu
    So, Hon-Cheong
    ASIAN JOURNAL OF PSYCHIATRY, 2024, 100
  • [45] Naturalistic impact of second-generation antipsychotics on weight gain
    Brixner, DI
    Said, Q
    Corey-Lisle, PK
    Tuomari, AV
    L'Italien, GJ
    Stockdale, W
    Oderda, GM
    ANNALS OF PHARMACOTHERAPY, 2006, 40 (04) : 626 - 632
  • [46] SECOND GENERATION ANTIPSYCHOTICS IN COMMUNITY TREATMENT FOR SCHIZOPHRENIA
    Keller, William R.
    Fischer, Bernard A.
    Meyer, Walter
    Reed, Marianne
    Blake, Melissa
    McMahon, R.
    Buchanan, Robert W.
    SCHIZOPHRENIA BULLETIN, 2011, 37 : 98 - 98
  • [47] Impact of second-generation antipsychotics on mitochondrial bioenergetics after acute treatment in rats
    Di Nunzio, Giada
    Santamaria, Raphael
    Fonseca, Ana Catarina
    Petkovic, Marija
    Santos, Diana
    Piscosquito, Arianna
    Carvalho, Eugenia
    Jones, John
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2019, 49 : 111 - 111
  • [48] Second-generation long-acting injectable antipsychotics in schizophrenia: patient functioning and quality of life
    Montemagni, Cristiana
    Frieri, Tiziana
    Rocca, Paola
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2016, 12 : 917 - 929
  • [49] Role of Long-Acting Injectable Second-Generation Antipsychotics in the Treatment of First-Episode Schizophrenia: A Clinical Perspective
    Prikryl, Radovan
    Kucerova, Hana Prikrylova
    Vrzalova, Michaela
    Ceskova, Eva
    SCHIZOPHRENIA RESEARCH AND TREATMENT, 2012, 2012
  • [50] Switching a combination of first- and second-generation antipsychotic polypharmacy to antipsychotic monotherapy in long-term inpatients with schizophrenia and related disorders. The SwAP trial II: Results on side effects
    Shakir, Mushde
    van Harten, Peter N.
    Hoogendoorn, Adriaan W.
    Willems, Anne E.
    Tenback, Diederik E.
    SCHIZOPHRENIA RESEARCH, 2024, 274 : 105 - 112
12345